A drug with the SMILES Cc1c(C(=O)N(C)C)sc(NC(=O)c2cc([N+](=O)[O-])cc([N+](=O)[O-])c2)c1C#N has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 5.425\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
Cc1c(C(=O)N(C)C)sc(NC(=O)c2cc([N+](=O)[O-])cc([N+](=O)[O-])c2)c1C#N
Cc1c(C(=O)N(C)C)sc(NC(=O)c2cc([N+](=O)[O-])cc([N+](=O)[O-])c2)c1C#N
4-cyano-5-[(3,5-dinitrobenzoyl)amino]-N,N,3-trimethylthiophene-2-carboxamide